Use of the helical SUPERA™ stent and Passeo-18 Lux™ drug-coated balloon to treat recurrent cephalic arch stenosis for dysfunctional brachiocephalic fistulas: 1 year results of the Arch V SUPERA-LUX study [0.03%]
用于治疗内乳动脉瘤样扩张的SUPERA螺旋支架和Passeo-18Lux药物涂层球囊：来自Arch V SUPERA-LUX研究一年期结果
Tjun Yip Tang,Shereen Xue Yun Soon,Charyl Jia Qi Yap et al.
Tjun Yip Tang et al.
Background: Aim of Arch V SUPERA-LUX was to evaluate the safety and efficacy of the combination therapy of SUPERA™ (Abbott Vascular, Santa Clara, CA, USA) helical stent implantation and Passeo-18 Lux™ (Biotronik Asia Pa...
A scoping review of Clinical Studies, Hospital Group Reports and National Strategic Documents on vascular access devices in cancer patients [0.03%]
关于癌症患者血管通路设备的临床研究、医院团体报告和国家战略文件的范围审查
Jennifer Clesham,Helen Reynolds,Peter J Carr
Jennifer Clesham
Introduction: The extent of vascular/venous access device (VAD) research output from the Island of Ireland is unknown. The identification of the papers available is important to create a future research agenda. ...
Lawrie Katerina,O&#x;Neill Stephen,Waldauf Petr et al.
Lawrie Katerina et al.
Background: VAVASC study (Validation of Arterio Venous Access Stage Classification) is a multicentre, international, prospective study. The study aims to validate the AVAS classification, which is a classification system ...
Matthew Ostroff,Kate Aberger,Nancy Moureau
Matthew Ostroff
Maintaining peripheral vascular access represents a major challenge for medical providers and patients leading to the emergence of ultrasound guided vascular access teams. Upper extremity peripheral vascular access options are often limited...
Use of Surfacer, an inside-out device, in tandem with HeRO graft for creation of vascular access: Case report of three patients with 18-months follow up [0.03%]
Surfacer与HeRO移植物联合使用建立血管通路的临床应用：三例患者18个月随访报告
Teo Qi Tian,Yap Hao Yun,Tay Jia Sheng et al.
Teo Qi Tian et al.
The Surfacer Inside-Out Access Catheter System (Surfacer) is a novel approach to restore access in total central vein occlusion (TCVO). We report a series of three cases, with mean 18-months follow up, in our institution where this techniqu...
Midline catheters for extracorporeal photopheresis in hematological patients [0.03%]
血液病患者体外光化学诱导疗法的中线导管护理要点及并发症防治进展
Bruno Marche,Sonia D&#x;Arrigo,Maria Giuseppina Annetta et al.
Bruno Marche et al.
Introduction: Peripheral venous access for extracorporeal photopheresis (ECP) may be difficult in graft versus host disease (GVHD) patients, because of previous intravenous therapies and multiple peripheral cannulations; ...
The SIF protocol: A seven-step strategy to minimize complications potentially related to the insertion of femorally inserted central catheters [0.03%]
SIF 协议：最小化股静脉置入中心导管潜在并发症的七步策略
Fabrizio Brescia,Mauro Pittiruti,Matthew Ostroff et al.
Fabrizio Brescia et al.
The insertion of central venous catheters through the femoral veins is not uncommon and is potentially associated with the risk of immediate puncture-related complications and severe late complications as infection and thrombosis. As for ot...
Mid-term cumulative patency of fistula and PTFE grafts among hemodialysis patients: A retrospective, single-center study from Palestine [0.03%]
巴勒斯坦肾透析患者的内瘘和PTFE移植物中期通畅情况：一项单中心回顾性研究
Obada Khanfar,Ramadan Aydi,Sultan Saada et al.
Obada Khanfar et al.
Background: Due to the long waiting time for kidney transplantation, most End-Stage renal disease patients are commenced on either hemodialysis or peritoneal dialysis. Reusable fistulas have the lowest risk for death, car...
Creating reverse flow arteriovenous fistulas with a forearm cannulation target [0.03%]
以手臂穿刺为目标的反流动动脉静脉内瘘手术创建
Hyein Kim,Peter R Nelson,Nasir Mushtaq et al.
Hyein Kim et al.
Background: Establishing a forearm arteriovenous fistula (AVF) offers preferred cannulation sites and preserves proximal access opportunities. When a radiocephalic AVF at the wrist is not feasible and the upper arm cephal...
Yeshwanter Radhakrishnan,Jayaprakash Dasari,Evamaria Anvari et al.
Yeshwanter Radhakrishnan et al.
One of the most challenging aspects of providing end-stage kidney disease care is to achieve adequate long-term access to the bloodstream to support hemodialysis (HD) therapy. Although upper extremity arteriovenous fistula remains the vascu...